Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
* Doctor-Formulated for Real Results Developed with science in mind to support energy, vitality, blood sugar balance, and overall wellness without harsh stimulants
Novo Nordisk Fair Value Estimate: $80.00 Morningstar Rating: 2 stars Morningstar Economic Moat Rating: Wide Morningstar Uncertainty Rating: High Were raising our fair value estimate of Novo Nordisk to $80 from $70 after updating our long-term GLP-1 model to include wider use and greater adherence
doi: 10.1038/s41575-019-0144-8 189 LassaillyGCaiazzoRBuobDPigeyreMVerkindtHLabreucheJet al
Obesity Market: The obesity drug market is experiencing even more rapid expansion
US$ 27.72
US$ 22.34
US$ 24.19
US$ 23.84
US$ 26.51
US$ 22.31
US$ 23.18
US$ 27.50
US$ 24.32
US$ 29.30
US$ 27.69
US$ 28.27
US$ 20.93
US$ 26.93
US$ 27.95
